The effect of rubber closures on the haze state of ceftriaxone sodium for injection

被引:18
作者
Zhao, Xia [1 ]
Jin, Shao-Hong [1 ]
Hu, Chang-Qin [1 ]
机构
[1] Natl Inst Control Pharmaceut & Biol Prod, Beijing 100050, Peoples R China
关键词
rubber closures; GC-MS; ceftriaxone sodium; BHT; headspace method; compatibility;
D O I
10.1080/03639040600815228
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The migration of volatile components into the headspace of glass vials from rubber closures is a potential source of haze formation in reconstituted solutions of powders for parenteral administration. In this paper, a headspace method was used to extract volatile substances from different types of rubber closures used in ceftriaxone sodium for injection whose clarity were poor. The extracts obtained were analyzed by gas chromatography (GC)-mass spectrometry (MS). An antioxidant in rubber closures, butylated hydroxytoluene (BHT), was found to affect the haze state of ceftriaxone sodium for injection.
引用
收藏
页码:35 / 44
页数:10
相关论文
共 17 条
[1]   PHARMACEUTICAL ASPECTS OF GLASS AND RUBBER [J].
BERRY, H .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1953, 5 (12) :1008-1023
[2]   INTERFERENCE BY BUTYL RUBBER STOPPERS IN GLC ANALYSIS FOR THEOPHYLLINE [J].
CHRZANOWSKI, F ;
NIEBERGALL, PJ ;
MAYOCK, R ;
TAUBIN, J ;
SUGITA, E .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1976, 65 (05) :735-736
[3]   Analysis of low-molar-mass materials in commercial rubber samples by Soxhlet and headspace extractions followed by GC-MS analysis [J].
Delaunay-Bertoncini, N ;
van der Wielen, FWM ;
de Voogt, P ;
Erlandsson, B ;
Schoenmakers, PJ .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2004, 35 (05) :1059-1073
[4]  
JAEHNKE RWO, 1990, J PARENT SCI TECHN, V44, P282
[5]   BLEOMYCIN AND CYCLOPHOSPHAMIDE TOXICITY IN MICE WITH DAMAGED LUNG-TISSUE [J].
KEHRER, JP .
TOXICOLOGY, 1989, 57 (01) :69-82
[6]   STABILITY OF ANTIBACTERIAL PRESERVATIVES IN PARENTERAL SOLUTIONS .4. CONTRIBUTION OF RUBBER CLOSURE COMPOSITION ON PRESERVATIVE LOSS [J].
LACHMAN, L ;
URBANYI, T ;
WEINSTEIN, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1963, 52 (03) :244-&
[7]  
Leebron K S, 1981, J Parenter Sci Technol, V35, P100
[8]  
MALDENER G, 1986, CONT ED COURS INT AS
[9]  
Pikal M J, 1978, J Parenter Drug Assoc, V32, P162
[10]  
PORTNOFF J B, 1983, Journal of Parenteral Science and Technology, V37, P180